BioCentury
ARTICLE | Financial News

Heptares secures $21 million in series B

June 28, 2013 1:17 AM UTC

Heptares Therapeutics Ltd. (Welwyn Garden City, U.K.) secured $21 million in a tranched series B round co-led by new investor Stanley Family Foundation and existing investor Clarus Ventures. Existing ...